ES2069742T3 - Proteina de la capsida del calicivirus felino y secuencia nucleotida. - Google Patents

Proteina de la capsida del calicivirus felino y secuencia nucleotida.

Info

Publication number
ES2069742T3
ES2069742T3 ES90911095T ES90911095T ES2069742T3 ES 2069742 T3 ES2069742 T3 ES 2069742T3 ES 90911095 T ES90911095 T ES 90911095T ES 90911095 T ES90911095 T ES 90911095T ES 2069742 T3 ES2069742 T3 ES 2069742T3
Authority
ES
Spain
Prior art keywords
protein
feline calicivirus
nucleotide sequence
calicivirus capsid
dna molecules
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES90911095T
Other languages
English (en)
Inventor
Richard C Wardley
Leonard Edwin Post
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Pharmacia and Upjohn Co
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Application granted granted Critical
Publication of ES2069742T3 publication Critical patent/ES2069742T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
    • C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/40—Fusion polypeptide containing a tag for immunodetection, or an epitope for immunisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide
    • C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
    • C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
    • C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/16011—Caliciviridae
    • C12N2770/16022—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biochemistry (AREA)
  • Communicable Diseases (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

LA PRESENTE INVENCION PRESENTA MOLECULAS DE ADN RECOMBINANTES QUE CONTIENEN UNA SECUENCIA QUE CODIFICA UN POLIPEPTIDO DEL CALICIVIRUS DE LOS FELINOS, EN PARTICULAR LA PROTEINA CAPSIDA, CELULAS HUESPEDES TRANSFORMADAS POR DICHAS SECUENCIAS DE MOLECULAS DE ADN RECOMBINANTES Y LOS POLIPEPTIDOS CAPSIDICOS. LA PRESENTE INVENCION PRESENTA TAMBIEN VACUNAS SUBUNITARIAS Y VACUNAS MULTIVALENTES PARA EL FCV.
ES90911095T 1989-07-21 1990-07-09 Proteina de la capsida del calicivirus felino y secuencia nucleotida. Expired - Lifetime ES2069742T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US38390989A 1989-07-21 1989-07-21
US40898989A 1989-09-18 1989-09-18

Publications (1)

Publication Number Publication Date
ES2069742T3 true ES2069742T3 (es) 1995-05-16

Family

ID=27010385

Family Applications (1)

Application Number Title Priority Date Filing Date
ES90911095T Expired - Lifetime ES2069742T3 (es) 1989-07-21 1990-07-09 Proteina de la capsida del calicivirus felino y secuencia nucleotida.

Country Status (9)

Country Link
EP (1) EP0484382B1 (es)
JP (1) JPH04506900A (es)
AT (1) ATE119545T1 (es)
AU (1) AU629381B2 (es)
CA (1) CA2055598C (es)
DE (1) DE69017687T2 (es)
DK (1) DK0484382T3 (es)
ES (1) ES2069742T3 (es)
WO (1) WO1991001332A1 (es)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5989561A (en) * 1991-03-07 1999-11-23 Virogenetics Corporation Recombinant poxvirus-calicivirus rabbit hemorrhagic disease virus (RHDV) compositions and uses
AU661106B2 (en) * 1992-02-28 1995-07-13 Juridical Foundation The Chemo-Sero-Therapeutic Research Institute Anti-feline calicivirus recombinant antibody and gene fragment encoding the same
ES2080023B1 (es) * 1994-07-08 1996-08-16 Iberica Cyanamid Capsidas y proteinas recombinantes del virus de la enfermedad hemorragica del conejo (rhdv), kits de diagnostico y vacunas que contienen dichos productos recombinantes.
FR2741806B1 (fr) * 1995-11-30 1998-02-20 Rhone Merieux Vaccin vivant recombinant a base d'herpesvirus felin de type 1, notamment contre la peritonite infectieuse feline
FR2751223B1 (fr) * 1996-07-19 1998-12-04 Rhone Merieux Formule de vaccin polynucleotidique felin
US6231863B1 (en) 1997-06-10 2001-05-15 American Cyanamid Company DNA sequences, molecules, vectors and vaccines for feline calicivirus disease and methods for producing and using same
AU5329300A (en) 1999-06-10 2001-01-02 Michigan State University Feline calicivirus isolated from cat urine and vaccines thereof
FR2796282B1 (fr) * 1999-07-16 2001-10-26 Merial Sas Vaccin inactive contre la calicivirose feline
FR2796397B1 (fr) * 1999-07-16 2006-09-01 Merial Sas Genes de calicivirus felin et vaccins notamment vaccins recombines
FR2796396A1 (fr) * 1999-07-16 2001-01-19 Merial Sas Gene de calicivirus felin et vaccin recombine les incorporant
US6541458B1 (en) 1999-07-16 2003-04-01 Merial Feline calicivirus genes and vaccines in particular recombinant vaccines
WO2005080416A1 (en) * 2004-01-20 2005-09-01 Pharmacia & Upjohn Company Llc Feline calicivirus vaccines
ATE496629T1 (de) * 2005-07-28 2011-02-15 Pfizer Prod Inc Impfstoff gegen felines calicivirus (fcv), der ein fcv kapsid protein oder ein isoliertes fcv kapsid protein mit der protein sequenz seq id no: 13 oder mit einer protein sequenz, die zumindestens zu 95 identisch zur seq id no: 13 ist enthält.
AU2016308630B2 (en) 2015-08-20 2019-09-19 Boehringer Ingelheim Animal Health USA Inc. FCV recombinant vaccines and uses thereof
ES2926813T3 (es) * 2015-12-23 2022-10-28 Intervet Int Bv Vacuna contra el calicivirus felino
CN109207441B (zh) * 2018-08-12 2022-05-27 扬州大学 重组杆状病毒表达猪圆环病毒3型Cap蛋白及其构建方法与引物

Also Published As

Publication number Publication date
CA2055598C (en) 1998-12-08
EP0484382A1 (en) 1992-05-13
DE69017687D1 (de) 1995-04-13
AU629381B2 (en) 1992-10-01
EP0484382B1 (en) 1995-03-08
ATE119545T1 (de) 1995-03-15
WO1991001332A1 (en) 1991-02-07
DK0484382T3 (da) 1995-07-24
CA2055598A1 (en) 1991-01-22
AU6037990A (en) 1991-02-22
DE69017687T2 (de) 1995-10-19
JPH04506900A (ja) 1992-12-03

Similar Documents

Publication Publication Date Title
ES2059565T3 (es) Virus mva de la vacuna, recombinante.
ES2054878T3 (es) Expresion de la proapolipoproteina a-i humana.
DK0640133T3 (da) Rekombinante DNA-molekyler, der koder for aminopeptidaseenzymer og deres anvendelse i fremstillingen af vacciner mod helmin
MX9204685A (es) Secuencia de adn que codifica una proteina superficial externa (ospa) o derivado de la misma composicion de vacuna qe comprende tal proteina.
CY1106350T1 (el) Εμβολιο φυματιωσης
MX9203379A (es) Proteinas producidas por los linfocitos humanos, secuencia de adn que codifica para estas proteinas y composiciones farmaceuticas que las contienen.
ES2165851T3 (es) Proteinas multivalentes que se unen a antigenos.
AR247761A1 (es) Metodo para producir un polipeptido en una celula hospedante de kluyveromyces, dicha celula hospedante transformada y secuencia a adn empleada
ES2140418T3 (es) Flavivirus quimericos y/o flavivirus de crecimiento restringido.
AR038568A1 (es) Anticuerpos anti-a beta y su uso
SG60387G (en) Recombinant dna, hosts transformed with it and polypeptides; compositions and means containing the polypeptides; dna sequences
ATE334216T1 (de) Impstoff gegen felines immunodefizienz-virus
ES2029171A6 (es) Un procedimiento para preparar un polipeptido virico de hepatitis no a y no b post-transfusional (pt-nanbh)
ES2103928T3 (es) Polipeptidos de mycobacterium y acidos nucleicos que los codifican utilizados en el diagnostico y el tratamiento de la tuberculosis.
ES2054701T3 (es) Clonacion y expresion de dna conteniendo el codigo de la toxina bordetella pertussis.
CO5560591A2 (es) Vacunas de adn optimizadas por el codon vih-gag
ES2144399T3 (es) Clonado del adn de virus de anemia de los pollos.
DK0484382T3 (da) Felint calicivirus-capsid-protein og nucleotidsekvens
ES2174835T3 (es) Carboxilasa dependiente de la vitamina k.
GB9219936D0 (en) Vaccines
AR009365A1 (es) Vacunas del virus de la fiebre aftosa (fmdv), peptidos, secuencias de adn y el uso de los peptidos en sistemas de deteccion y el uso de la vacuna fmdc para la preparacion de una composicion para inmunizar cerdos y ganado vacuno
ES2076930T3 (es) Moleculas de adn utiles en la proteccion de plantas.
PE20001287A1 (es) Composicion farmaceutica que contiene fragmentos de adn codificador de una proteina antigenica con efecto antitumoral
ES2118242T3 (es) Vacunas anti virus de la inmunodeficiencia felina (fiv).
ES2074422T3 (es) Moleculas de adn y arn del subtipo accidental del virus fsma, polipeptidos, que son codificados por estas moleculas, y su uso.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 484382

Country of ref document: ES